Key Takeaways On April 1, 2026, FDA issued a statement reminding 503A pharmacies and 503B outsourcing facilities that ...

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.

I’m talking about “compounding.” But not in the way you’re probably thinking. Most of us learned about the power of “compound interest” in school. Compounding works in dividend-paying stocks, too. You ...

Gottlieb was commissioner of the Food and Drug Administration from 2017 to 2019. When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife ...